Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jason Matthew
Jason Matthew Mitmesser, Jeffersonville, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090052818 | Hybrid bearing - One embodiment of a hybrid vertical axis rotating load carrying bearing with continuously variable operating conditions able to carry surprisingly heavy weight, and occasionally easily able to carry drastically more weight than that; The preferred embodiment has 3 different types of bearings combined to form one ideal bearing. The first type of bearing is a half ball and female sliding bearing. The second type of bearing is a floating bearing that surrounds the sliding bearing. The third type of bearing is rolling bearings. In this preferred embodiment with 3 different types of bearings, the rolling bearings are partially engaged under ideal load weight conditions, and nearly fully engaged under severe load weight conditions. The sliding and floating bearings are always fully engaged into the vertical weight load no matter what the vertical weight load may be. | 02-26-2009 |
| 20090108587 | Hybrid vertical axis wind turbine - One embodiment of a hybrid vertical axis wind turbine with a big annular generator ( | 04-30-2009 |
Jason Matthew Mittmesser, Jeffersonville, IN US
Jason Matthew Ochoada, Greenwood, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20080306125 | Compounds and Methods for Modulating Fx-Receptors - Compounds of formula. wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases. | 12-11-2008 |
| 20090093524 | COMPOUNDS AND METHODS FOR MODULATING FXR - Compounds of formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases. | 04-09-2009 |
| 20090270460 | FXR AGONISTS - Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases. | 10-29-2009 |
